
Sign up to save your podcasts
Or


Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli covers the news that Merck will buy Prometheus Biosciences for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. Irving Fain, CEO of Bowery Farming, discusses disruption in the vertical farming space. Honeycomb CEO Christine Yen talks about new funding for the observability cloud platform. And We Drive to the Close with Doug Ciocca, CEO at Kavar Capital.
Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
376376 ratings
Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli covers the news that Merck will buy Prometheus Biosciences for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. Irving Fain, CEO of Bowery Farming, discusses disruption in the vertical farming space. Honeycomb CEO Christine Yen talks about new funding for the observability cloud platform. And We Drive to the Close with Doug Ciocca, CEO at Kavar Capital.
Hosts: Carol Massar and Madison Mills. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.

1,724 Listeners

971 Listeners

404 Listeners

1,189 Listeners

2,187 Listeners

969 Listeners

683 Listeners

196 Listeners

1,051 Listeners

1,304 Listeners

64 Listeners

30 Listeners

63 Listeners

4 Listeners

58 Listeners

233 Listeners

230 Listeners

66 Listeners

87 Listeners

77 Listeners

85 Listeners

83 Listeners

404 Listeners

9 Listeners

22 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

26 Listeners